Literature DB >> 408918

Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence.

E A Edwards, L F Devine, G H Sengbusch, H W Ward.   

Abstract

A surveillance program to determine group C meningococcal acquisition in military personnel during an epidemic was made. Data from fortnightly nasopharyngeal cultures show that individuals who were admitted with meningococcal disease acquired the organism within a week of disease onset. There were 24 company/platoons in which a single case occurred. Six company/platoons had 2 cases each. While other conditions which could act as predisposing factors were not ruled out, the data here favor acute respiratory disease as a predisposing factor(s) that may cause the increased incidence of meningococcal disease seen in military recruits. The exact mechanism is yet to be defined.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408918     DOI: 10.3109/inf.1977.9.issue-2.09

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  31 in total

1.  Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage.

Authors:  P Mölling; A Bäckman; P Olcén; H Fredlund
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

2.  Guidelines for controlling meningococcal disease.

Authors: 
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

Review 3.  Global epidemiology of meningococcal disease.

Authors:  B Schwartz; P S Moore; C V Broome
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.

Authors:  C Hal Jones; Naglaa Mohamed; Eduardo Rojas; Lubomira Andrew; Johanna Hoyos; Julio C Hawkins; Lisa K McNeil; Qin Jiang; Leonard W Mayer; Xin Wang; Rodica Gilca; Philippe De Wals; Louise Pedneault; Joseph Eiden; Kathrin U Jansen; Annaliesa S Anderson
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

5.  Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.

Authors:  Siamak P Yazdankhah; Paula Kriz; Georgina Tzanakaki; Jenny Kremastinou; Jitka Kalmusova; Martin Musilek; Torill Alvestad; Keith A Jolley; Daniel J Wilson; Noel D McCarthy; Dominique A Caugant; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Importance of complement source in measuring meningococcal bactericidal titers.

Authors:  G F Santos; R R Deck; J Donnelly; W Blackwelder; D M Granoff
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

7.  Failure of chemoprophylaxis to prevent meningococcal disease.

Authors:  G Foster; H Panigrahi; M Walker
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-29

8.  Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.

Authors:  Dominic F Kelly; Matthew D Snape; Kirsten P Perrett; Elizabeth A Clutterbuck; Susan Lewis; Geraldine Blanchard Rohner; Meryl Jones; Ly-Mee Yu; Andrew J Pollard
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

9.  Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37.

Authors:  K L Seib; D Serruto; F Oriente; I Delany; J Adu-Bobie; D Veggi; B Aricò; R Rappuoli; M Pizza
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

Review 10.  Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.

Authors: 
Journal:  CMAJ       Date:  1994-06-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.